Only Two-thirds Pharmaceutical Companies Fully Operational

  2 min 11 sec to read
Only Two-thirds Pharmaceutical Companies Fully Operational

July 4: Only about two-thirds of registered pharmaceutical companies in the country are fully operational at present. This was revealed in a detailed study report on self-reliant pharmaceuticals and drug manufacturing industries of Nepal released by the Department of Industry on Saturday.

According to the report, there are 103 pharmaceutical companies registered with the Department of Drug Administration as of April 25, 2021, of which only 66 companies are fully operational. The department informed that these companies have received licenses for both production and sales of medicines. Similarly, the report states that 33 companies are in the process of obtaining licenses for production, while other four licensed industries are not operating due to technical reasons.

Out of 66 companies, four (6.06 percent) companies are in Province 1, 14 (21.21 percent) are in Province 2, Bagmati Province has 37 (56.06 percent) companies, Gandaki has 2 (3.03 percent) companies and Lumbini Province has 9 (13.63 percent) companies. The study report shows that there isn’t any pharmaceutical company in the other two provinces.

All the above-mentioned pharmaceutical companies are private and mostly large (90 percent) with a total capital of more than Rs 250 million. Some medium-sized companies (10 percent) are also planning to increase investment.

Most of the companies in operation are producing medicines in the form of tablets, capsules, liquid (syrup/suspension), powder (dry syrup), ointment/cream and eye/ear drops.

The yearly production capacity of tablets of 60 out of 66 companies is 2 billion units and the production capacity of capsules is 1.75 billion units. Similarly, the production capacity of liquid medicine of 45 companies is 4.5 billion units. In addition, the ointment production capacity of 40 companies is 150 million units and powder (dry syrup) is 30 million units. Moreover, the production capacity of nose/ear drops of five companies is 3.7 million units.  

 

No comments yet. Be the first one to comment.